TY - JOUR
T1 - Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamine
AU - Sigmon, Stacey C.
AU - Griffiths, Roland R.
N1 - Funding Information:
Funding for this study was provided by grants R01-DA03890 (RRG) and T32-DA07209 (GEB) from the National Institute on Drug Abuse (NIDA). The NIDA had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.
PY - 2011/11/1
Y1 - 2011/11/1
N2 - Background: Individuals vary in their subjective and behavioral response to psychomotor stimulants and these differences may be associated with the likelihood of developing problematic use of these drugs. The present study sought to determine whether individual differences in caffeine choice prospectively predict subjective response to acute doses of caffeine and d-amphetamine. Methods: In Phase 1, Choosers and Nonchoosers of caffeine were identified using 10 independent choice trials in which subjects repeatedly chose between caffeine (200. mg/70. kg) and placebo. Choosers were defined as those who chose caffeine over placebo on ≥7 of the 10 trials; Nonchoosers were those who chose placebo on ≥7 trials. In Phase 2, Choosers and Nonchoosers were compared in their subjective response to caffeine (100, 200, 400. mg/70. kg) and d-amphetamine (5, 10, 20. mg/70. kg). Results: Of the 22 participants completing the study, 11 met criteria for being a caffeine Chooser and 8 were Nonchoosers. In Phase 1, Choosers reported higher ratings of positive (i.e., pleasant) and lower ratings of negative (i.e., unpleasant) effects of caffeine during the sampling sessions. In Phase 2, caffeine Choosers reported more positive subjective effects and fewer negative effects of caffeine and d-amphetamine, particularly at the highest doses examined. Conclusions: Individual differences in caffeine reinforcement predicted subsequent subjective response to both d-amphetamine and caffeine. This observation may have clinical utility for identifying individuals who are vulnerable to the reinforcing effects of abused psychomotor stimulants.
AB - Background: Individuals vary in their subjective and behavioral response to psychomotor stimulants and these differences may be associated with the likelihood of developing problematic use of these drugs. The present study sought to determine whether individual differences in caffeine choice prospectively predict subjective response to acute doses of caffeine and d-amphetamine. Methods: In Phase 1, Choosers and Nonchoosers of caffeine were identified using 10 independent choice trials in which subjects repeatedly chose between caffeine (200. mg/70. kg) and placebo. Choosers were defined as those who chose caffeine over placebo on ≥7 of the 10 trials; Nonchoosers were those who chose placebo on ≥7 trials. In Phase 2, Choosers and Nonchoosers were compared in their subjective response to caffeine (100, 200, 400. mg/70. kg) and d-amphetamine (5, 10, 20. mg/70. kg). Results: Of the 22 participants completing the study, 11 met criteria for being a caffeine Chooser and 8 were Nonchoosers. In Phase 1, Choosers reported higher ratings of positive (i.e., pleasant) and lower ratings of negative (i.e., unpleasant) effects of caffeine during the sampling sessions. In Phase 2, caffeine Choosers reported more positive subjective effects and fewer negative effects of caffeine and d-amphetamine, particularly at the highest doses examined. Conclusions: Individual differences in caffeine reinforcement predicted subsequent subjective response to both d-amphetamine and caffeine. This observation may have clinical utility for identifying individuals who are vulnerable to the reinforcing effects of abused psychomotor stimulants.
KW - Caffeine
KW - D-Amphetamine
KW - Individual differences
KW - Psychomotor stimulant
KW - Reinforcement
KW - Subjective effects
UR - http://www.scopus.com/inward/record.url?scp=80053573925&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80053573925&partnerID=8YFLogxK
U2 - 10.1016/j.drugalcdep.2011.04.018
DO - 10.1016/j.drugalcdep.2011.04.018
M3 - Article
C2 - 21600707
AN - SCOPUS:80053573925
SN - 0376-8716
VL - 118
SP - 341
EP - 348
JO - Drug and alcohol dependence
JF - Drug and alcohol dependence
IS - 2-3
ER -